Nie Yongzhan, Hammond Graeme L, Yang Jing-Hua
Department of Surgery, Yale University School of Medicine, New Haven, CT 06520, USA.
J Virol. 2007 Jan;81(2):917-23. doi: 10.1128/JVI.01527-06. Epub 2006 Nov 1.
The RNA-editing enzyme ADAR1 is a double-stranded RNA (dsRNA) binding protein that modifies cellular and viral RNA sequences by adenosine deamination. ADAR1 has been demonstrated to play important roles in embryonic erythropoiesis, viral response, and RNA interference. In human hepatitis virus infection, ADAR1 has been shown to target viral RNA and to suppress viral replication through dsRNA editing. It is not clear whether this antiviral effect of ADAR1 is a common mechanism in response to viral infection. Here, we report a proviral effect of ADAR1 that enhances replication of vesicular stomatitis virus (VSV) through a mechanism independent of dsRNA editing. We demonstrate that ADAR1 interacts with dsRNA-activated protein kinase PKR, inhibits its kinase activity, and suppresses the alpha subunit of eukaryotic initiation factor 2 (eIF-2alpha) phosphorylation. Consistent with the inhibitory effect on PKR activation, ADAR1 increases VSV infection in PKR+/+ mouse embryonic fibroblasts; however, no significant effect was found in PKR-/- cells. This proviral effect of ADAR1 requires the N-terminal domains but does not require the deaminase domain. These findings reveal a novel mechanism of ADAR1 that increases host susceptibility to viral infection by inhibiting PKR activation.
RNA 编辑酶 ADAR1 是一种双链 RNA(dsRNA)结合蛋白,可通过腺苷脱氨作用修饰细胞和病毒的 RNA 序列。ADAR1 已被证明在胚胎红细胞生成、病毒反应和 RNA 干扰中发挥重要作用。在人类肝炎病毒感染中,ADAR1 已被证明可靶向病毒 RNA 并通过 dsRNA 编辑抑制病毒复制。目前尚不清楚 ADAR1 的这种抗病毒作用是否是应对病毒感染的常见机制。在这里,我们报告了 ADAR1 的一种前病毒效应,即通过一种独立于 dsRNA 编辑的机制增强水疱性口炎病毒(VSV)的复制。我们证明 ADAR1 与 dsRNA 激活的蛋白激酶 PKR 相互作用,抑制其激酶活性,并抑制真核起始因子 2(eIF-2α)α 亚基的磷酸化。与对 PKR 激活的抑制作用一致,ADAR1 在 PKR+/+ 小鼠胚胎成纤维细胞中增加 VSV 感染;然而,在 PKR-/- 细胞中未发现显著影响。ADAR1 的这种前病毒效应需要 N 端结构域,但不需要脱氨酶结构域。这些发现揭示了 ADAR1 的一种新机制,即通过抑制 PKR 激活增加宿主对病毒感染的易感性。